Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

306.37
Delayed Data
As of Jun 18
 +6.21 / +2.07%
Today’s Change
13.10
Today|||52-Week Range
325.98
+233.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Operating ActivitiesNet Income / Starting Line-8.3M-8.4M-8.4M-6.4M
 
 
 
 
 
Depreciation--9.0K60.0K23.0K
 
 
 
 
Total Other Cash Flow676.0K1.0M947.0K1.2M
 
 
 
 
 
Funds From Operations-7.7M-7.3M-7.4M-5.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-13.0K-2.4M-1.5M3.5M
 
 
 
 
 
Net Cash Flow - Operating Activities-7.7M-5.0M-5.9M-8.6M
 
 
 
 
 
 
InvestingIncrease In Investments-9.0M-3.8M-35.3M-122.2M
 
 
 
 
 
Decrease In Investments8.5M-13.1M41.4M20.1M
 
 
 
 
 
Capital Expenditures-123.0K0.000.00-1.0K
 
 
 
Net Cash Flow Investing-647.0K-16.9M6.1M-102.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale34.9M0.00135.5M265.0K
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.00--0.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing34.9M0.00135.5M265.0K
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash26.6M-21.8M135.7M-110.5M